People: Arrowhead Research Corp (ARWR.O)

ARWR.O on Nasdaq

5.48USD
3 Sep 2015
Change (% chg)

-- (--)
Prev Close
$5.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,075,211
52-wk High
$17.42
52-wk Low
$4.35

Search Stocks

Frykman, Edward 

Mr. Edward W. Frykman is Independent Director of Arrowhead Research Corp. He has been a director of the Company since January 2004. Mr. Frykman was an Account Executive with Crowell, Weedon & Co., a position he held from 1992 until 2008 when he retired. Before his service at Crowell, Weedon & Co., Mr. Frykman served as Senior Vice President of L.H. Friend & Co. Both Crowell Weedon & Co. and L.H. Friend & Co. are investment brokerage firms located in Southern California. In addition, Mr. Frykman was a Senior Account Executive with Shearson Lehman Hutton, where he served as the Manager of the Los Angeles Regional Retail Office of E. F. Hutton & Co. Mr. Frykman is also a director of Acacia Research Corporation, a publicly-held corporation based in Newport Beach, California. Mr. Frykman is a director of Arrowhead’s majority-owned subsidiaries Calando Pharmaceuticals, Inc., Ablaris Therapeutics, Inc., and Tego Biosciences Corporation. We believe Mr. Frykman’s qualifications to serve on the Board include his long tenure as a member of the Board which enabled Mr. Frykman to gain a deep understanding of the company’s operations, strategy and finances. Mr. Frykman also has extensive experience in the fields of finance and public company oversight.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Douglass Given

--

Christopher Anzalone

4,638,140

Kenneth Myszkowski

1,897,210

Bruce Given

2,898,950

David Lewis

1,428,920

Susan Boynton

--
As Of  29 Sep 2014
Search Stocks